bf/NASDAQ:GH_icon.png

NASDAQ:GH

Guardant Health, Inc.

  • Stock

USD

Last Close

17.96

28/03 20:00

Market Cap

2.80B

Beta: 0.81

Volume Today

5.57M

Avg: 1.90M

PE Ratio

−5.81

PFCF: −7.12

  • industry

    Diagnostics & Research
  • exchange

    NASDAQ Global Select
  • website

    guardanthealth.com
  • ipo date

    Oct 04, 2018
  • full time employees

    1,793
  • currency

    USD

Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an...Show More

Earnings

Earnings per Share (Estimate*)

-2-1.5-1-0.52017-09-302019-05-092020-11-052022-05-052023-11-06

Revenue (Estimate*)

50M100M150M2017-09-302019-05-092020-11-052022-05-052023-11-06

*Estimate based on analyst consensus

founders

  • AmirAli Talasaz
  • Carlos Virella
  • Helmy Eltoukhy

investors

PartnersFunding RoundInvestor NameLead Investor
Brogan HarrisPost-IPO Equity - Guardant HealthBaillie GiffordYes
Venture Round - Guardant HealthMusea Ventures
Venture Round - Guardant HealthPlug and Play
Secondary Market - Guardant HealthEquityZen
Secondary Market - Guardant HealthStorm GlobalNo
Series E - Guardant HealthSequoia CapitalNo
Samir KaulSeries E - Guardant HealthKhosla VenturesNo
Series E - Guardant HealthTemasek HoldingsNo
Series E - Guardant HealthC.M. Capital AdvisorsNo
Christopher Schaepe, David ChenSeries E - Guardant HealthLightspeed Venture PartnersNo

investments

Money RaisedFunding RoundLead InvestorAnnounced DateOrganization Name
$26MSeries C - LunitYes19-07-2021Lunit

acquisitions

PriceAcquiree NameAnnounced DateTransaction Name
Bellwether Bio28-03-2019Bellwether Bio acquired by Guardant Health

num employees

  • 1001-5000

funding rounds

Money RaisedAnnounced DateLead InvestorsTransaction NameNumber of Investors
$90.7M21-12-2023Baillie GiffordPost-IPO Equity - Guardant Health1
$250M22-05-2023Post-IPO Equity - Guardant Health
06-08-2018Venture Round - Guardant Health2
16-07-2018Secondary Market - Guardant Health2
$360M11-05-2017SoftBank Vision FundSeries E - Guardant Health9
$100M07-01-2016OrbiMedSeries D - Guardant Health10
$50M03-02-2015Lightspeed Venture PartnersSeries C - Guardant Health7
$30M22-04-2014Khosla VenturesSeries B - Guardant Health5
$10M11-02-2014Sequoia CapitalSeries A - Guardant Health5
08-06-2012Seed Round - Guardant Health2

Please Sign In To Use The Chat

The chat is only available for registered users, please sign in or create your free account.